Whitepaper , Modified Release , Formulation Development , Translational Pharmaceutics

Alternative Strategies for Development of Modified Release Dosage Forms


Modified-release (MR) formulations are in high demand. For formulators, they enable drugs to be released in the optimal gastrointestinal (GI) locations to achieve and maintain desirable plasma concentrations for extended periods, avoiding undesirable excursions outside the therapeutic range.